We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-1.50 | -0.09% | 1,639.00 | 1,639.00 | 1,639.50 | 1,647.00 | 1,634.00 | 1,638.50 | 673,469 | 12:39:54 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 13.65 | 67.29B |
Date | Subject | Author | Discuss |
---|---|---|---|
24/3/2017 12:20 | M, would tend to agree. | essentialinvestor | |
24/3/2017 12:18 | Disappointedly, this looks like going closer to 1600p before it ever reaches 1700p again ..... ;0) | tradermichael | |
24/3/2017 10:26 | W/H,Very true, me too.Analysis are only a guide.Use for own judgement. | garycook | |
24/3/2017 09:37 | I have found, over the years, that I reliably make far more money by backing my own judgement and ignoring analysts and financial institutions than I ever did by taking their 'advice'. | woodhawk | |
24/3/2017 08:41 | Solomon,Totally agree with your post. | garycook | |
24/3/2017 08:36 | As others have pointed out, Soc Gen may have ulterior motives. Bankers, Financial analysts, (and I'll throw in lawyers) - leopards don't change their spots even if they are caught out once in a while. | solomon | |
24/3/2017 08:05 | So Soc Gen says AZN should be worth about £100b and GSK about £65b, i.e AZN should be worth 50% more than GSK. Does these guys have any common sense? How can they have any credibility with their clients and justify their fat pay with analysis and recommendation like that? | riskvsreward | |
23/3/2017 20:26 | See that Soc Gen issued a target price of 7600 for AZN today.... with the 1300 target for GSK I would like to see how both figures were arrived at .....sees a tad far fetched to me. | gwatson56 | |
23/3/2017 15:56 | Only about a third of that at the moment, Gary. I should probably diversify more, but I'm doing very well as it is, so little incentive as yet | woodhawk | |
23/3/2017 15:14 | W/H,We must overlap on a few stocks.I have 25,and you ? | garycook | |
23/3/2017 12:05 | Here too Gary? We obviously think along the same lines!! | woodhawk | |
23/3/2017 10:22 | Would love to buy some at £13.Be very lucky to get GSK at £15 again. | garycook | |
23/3/2017 10:18 | lol probably ..... m | maurillac | |
23/3/2017 09:34 | 1300? FFS. | essentialinvestor | |
23/3/2017 09:33 | edit:: Soc Gen cuts to 1300p target .. reiterates 'sell' | philanderer | |
22/3/2017 16:50 | Room for a nice 10% bounce here as Emma takes the reins and moves away from Witty's steady as she goes, overly cautious approach. | romeike | |
22/3/2017 14:11 | Yep that`s a bit unbalanced :-) Two up now AZN and HILS. Rubbish day | philanderer | |
22/3/2017 09:16 | Only one up in my own too. However decided to halve my holding, had grown to almost 60% of pf. Love the divis but felt uncomfortable with so much in one stock and good time to make use of years cap gains allowance | andyadvfn1 | |
22/3/2017 09:09 | Only one in my portfolio of twenty stocks up today :-) | philanderer | |
22/3/2017 09:05 | One of the few safe stocks to be in today? | andyadvfn1 | |
21/3/2017 20:34 | 'Still Bullish on GlaxoSmithKline' | philanderer | |
17/3/2017 09:23 | 17th march Berenberg buy tp 1890p up from 1850p | philanderer | |
16/3/2017 11:53 | we seem to be need a nudge to push through 1690, c`mon chaps ;) m | maurillac |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions